Fermentalg SA (EPA:ALGAE)

Market Cap	42.17M -4.3%
Revenue (ttm)	13.38M +16.4%
Net Income	-9.44M
EPS	-0.09
Shares Out	96.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,357
Open	0.4380
Previous Close	0.4380
Day's Range	0.4300 - 0.4400
52-Week Range	0.4000 - 0.6400
Beta	1.04
Analysts	Strong Buy
Price Target	0.64 (+45.79%)
Earnings Date	Oct 6, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 64
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGAE

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ALGAE stock is "Strong Buy." The 12-month stock price target is €0.64, which is an increase of 45.79% from the latest price.

Price Target

€0.64

(45.79% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 29, 2026

Data Sources Report a data error